跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXTROSE INJECTION USP 5% - HSA Drug Approval Details
Approvals
/
HSA
/
DEXTROSE INJECTION USP 5%
Approved
THERAPEUTIC
DEXTROSE INJECTION USP 5%
BAXTER HEALTHCARE CORPORATION (NORTH COVE) - UNITED STATESBAXTER HEALTHCARE PHILIPPINES INC - PHILIPPINESBAXTER HEALTHCARE CORPORATION (JAYUYA) - PUERTO RICOBAXTER HEALTHCARE CORPORATION (AIBONITO) (PUERTO RICO)
🇸🇬 Health Sciences Authority
Approval Date
Apr 8, 1991
Approval ID
049ad9be0771b2e8
Company
BAXTER HEALTHCARE CORPORATION (NORTH COVE) - UNITED STATESBAXTER HEALTHCARE PHILIPPINES INC - PHILIPPINESBAXTER HEALTHCARE CORPORATION (JAYUYA) - PUERTO RICOBAXTER HEALTHCARE CORPORATION (AIBONITO) (PUERTO RICO)
Type
Therapeutic
Approval Details
Approval Id
049ad9be0771b2e8
Drug Name
DEXTROSE INJECTION USP 5%
Product Name
DEXTROSE INJECTION USP 5%
Approval Number
SIN05728P
Approval Date
1991-04-08
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
V06DC01
Atc Item Name
glucose
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Active Ingredients
DEXTROSE ANHYDROUS 4.5 g/100 ml EQV DEXTROSE HYDROUS
5 g/100 ml
DEXTROSE ANHYDROUS 4.5 G/100 ML EQV DEXTROSE HYDROUS
5 G/100 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 8, 1991
Approval ID
049ad9be0771b2e8
Type
Therapeutic
Back to HSA Approvals